Pfizer (PFE) and Lilly (LLY) Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain

February 19, 2019 6:51 AM
Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from a Phase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles